Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation

Clinical trial NCT02002923 · UNKNOWN

Trial details

NCT number: NCT02002923
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Paroxysmal Atrial Fibrillation Persistent Atrial Fibrillation

Start date: 2013-06-01
Primary completion: 2015-06-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.